2. Search Result
Search Result
Results for "

Flunitrazepam

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-106316
    CGS 20625

    		GABA Receptor Neurological Disease
    CGS 20625 is a potent, selective and orally active partial agonist for the central benzodiazepine receptor. CGS 20625 inhibits [3H]-flunitrazepam binding to central benzodiazepine receptors with an IC50 of 1.3 nM. CGS 20625 enhances GABA in Xenopus laevis oocytes . CGS 20625 can be used for the research of pentylenetetrazol-induced seizures and anxiety .
    CGS 20625
  • HY-W104076
    2-Amino-2'-fluoro-5-nitrobenzophenone

    		Drug Metabolite Others
    2-Amino-2'-fluoro-5-nitrobenzophenone is a precursor in the synthesis of benzodiazepines. 2-Amino-2'-fluoro-5-nitrobenzophenone is also an acid hydrolysis product of Flunitrazepam.
    2-Amino-2'-fluoro-5-nitrobenzophenone
  • HY-111298
    TG 41

    		GABA Receptor Neurological Disease
    TG 41 is positive modulator of GABAA receptor. TG 41 enhances the binding both of GABA and of Flunitrazepam to rat cerebral cortical membranes .
    TG 41
  • HY-100924
    β-CCB

    		GABA Receptor Neurological Disease
    β-CCB is a ligand for benzodiazepine receptor, which inhibits the binding of [ 3H]flunitrazepam and ethyl (3-[ 3H]carboline-3-carboxylate to benzodiazepine receptors, with Ki of 3-4 nM. β-CCB exhibits proconvulsant and anxiogenic effects .
    β-CCB
  • HY-121116
    CGS 8216

    		GABA Receptor Neurological Disease
    CGS 8216 is a non-benzodiazepine brain benzodiazepine receptor ligand that binds to rat forebrain membranes with high affinity and specificity. CGS 8216 also inhibits 3H-flunitrazepam (3H-FLU) binding to rat synaptosomal membranes and blocks 3H-FLU labeling of brain benzodiazepine receptors in vivo with potency equivalent to Diazepam .
    CGS 8216
  • HY-116687
    7-Aminoflunitrazepam

    		Drug Metabolite Neurological Disease
    7-Aminoflunitrazepam is the main urinary metabolite of Flunitrazepam .
    7-Aminoflunitrazepam
  • HY-121057
    3-Hydroxyflunitrazepam

    3-OH FNTZ

    		 Drug Metabolite Cytochrome P450 Metabolic Disease
    3-Hydroxyflunitrazepam (3-OH FNTZ) is the major metabolite of Flunitrazepam (FNTZ), generated via 3-hydroxylation by CYP3A4 (Km = 286 μM), and represents the dominant metabolic pathway (>80%) in liver microsomes. Its formation is significantly inhibited by CYP3A4 inhibitors such as Ketoconazole (HY-B0105) (IC50 = 0.11 μM) and Ritonavir (HY-90001) (IC50 = 0.041 μM), indicating a strong dependence on CYP3A4 activity and potential drug interactions .
    3-Hydroxyflunitrazepam
  • HY-B1803
    Tracazolate

    ICI 136753

    		 GABA Receptor Neurological Disease
    Tracazolate (ICI 136753) is an orally active non-benzodiazepine anxiolytic. Tracazolate significantly enhances the binding of the radioligand 3H-flunitrazepam ( 3H-FLU) to brain tissue benzodiazepine receptors. Tracazolate enhances the binding of γ-aminobutyric acid (GABA) to its receptors. Tracazolate exhibits anticonvulsant activity. Tracazolate can be used in anxiety-related research .
    Tracazolate

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: